Distinctive symptoms
Register , to see more distinctive signs of diseases and studies 100% 28%
Register , to see more distinctive signs of diseases and studies 15% 100%
ovarian cysts
76%
13%
anemia —
7%
copious menstruation
52%
20%
vaginal —
7%
uterine cyst
55%
25%
adenomatous endometrial hyperplasia —
7%
clots menstruation
35%
9%
cysts and polyps —
6%
cyst of the left ovary
22%
—
cause pathological menopause —
5%
abundant menstruation with clots
21%
—
artificial climax —
5%
uterine polyps
27%
9%
vaginal sarcoma —
5%
uterine fibroids
32%
17%
fibrous endometrial polyp —
5%
monthly painful
13%
—
cervical cancer during pregnancy —
5%
myopia
13%
—
trophoblastic tumors —
5%
uterine tumor
30%
15%
ovulatory syndrome —
4%
pregnancy
19%
5%
uterine adenocarcinoma —
4%
bleeding uterine
23%
10%
menopause diseases —
4%
removal of ovaries
10%
—
cervical erosion —
4%
fibroma
24%
13%
multiple uterine fibroids —
4%
appendages of uterus are painful
9%
—
cervical polyp —
4%
ovarian pain
9%
—
benign vaginal tumors —
4%
bleeding
23%
12%
multiple fibroids —
4%
uterine infertility
7%
—
thyroid atrophy —
4%
желание иметь детей
7%
—
cervical fibroids —
4%
polyps
27%
18%
hypertrophy of the uterine body —
4%
ovarian endometriosis
12%
3%
anovulatory cycle —
4%
discharge after menstruation
6%
—
eroded uterine lining —
4%
huge stomach
6%
—
premenopause —
4%
gases when urinating
6%
—
abortions —
3%
adhesions in the pelvis
6%
—
medical abortion —
3%
follicular ovarian cyst
6%
—
solid tumors —
3%
follicular cyst
5%
—
mastopathy —
3%
adhesions in the intestines
5%
—
benign epithelial tumors —
3%
prolonged urination
5%
—
big head —
3%
uterine appendages are increase
5%
—
cervical pregnancy —
3%
constipation
5%
—
uterine fibroids during pregnancy —
3%
appendages of pain
5%
—
blood diseases —
3%
ovarian tumors in girls
5%
—
sudden dizziness —
3%
subacute condition
5%
—
vacuum —
3%
thyroid cyst thyroid gland
5%
—
bloody discharge from the vagina —
3%
inflammation of the ovaries
5%
—
adenomatous polyp —
3%
excess prolactin
5%
—
cervical cancer —
3%
nausea
5%
—
precancer —
3%
ovarian dysfunction
5%
—
anemia and weakness —
3%
worse during menstruation
5%
—
uterine cancer —
3%
primary infertility
5%
—
blood loss —
3%
bloating
5%
—
ectopic pregnancy —
3%
endometrial polyps
22%
15%
feeling of bruising —
3%
urination disorder
4%
—
late pregnancy —
3%
migrating larva
4%
—
dizziness weakness —
3%
purulent peritonitis
4%
—
bleeding during pregnancy —
3%
diseases of the gastrointestinal tract
4%
—
endocervicitis —
3%
emotional exhaustion
4%
—
posthemorrhagic anemia —
3%
sharp belly
4%
—
genital neoplasms —
3%
consequences of operation
4%
—
lack of menstruation —
3%
fever weakness
4%
—
dizziness severe —
3%
effects of taking hormones
4%
—
consequences of suppression —
3%
peritonitis
4%
—
weakness after illness —
2%
liver dysfunction
4%
—
sensations in the head —
2%
weakening of immunity
4%
—
dizziness —
2%
bleeding
4%
—
lymphosarcoma —
2%
alert
4%
—
hypertension —
2%
nervous exhaustion
4%
—
endometrial cancer
6%
8%
nausea with fever
4%
—
anovulatory infertility
4%
6%
gynecological operations
4%
—
menopause
3%
5%
acute pain
4%
—
fighting —
2%
impaired uterine function
11%
5%
polycystic
3%
4%
ovarian dysfunction
10%
4%
hypertension
2%
3%
lower abdominal pain
4%
—
diabetes mellitus
2%
3%
consequence of hormone treatment
4%
—
dependence on the doctor
2%
3%
volume of thyroid gland is reduced
4%
—
cystic fibrosis
3%
4%
abdominal pain
3%
—
polycystic ovary syndrome pcos
4%
5%
skin problems
3%
—
metastases
4%
5%
injury
3%
—
monthly prolonged
4%
5%
consequences of infection
3%
—
polycystic ovaries
3%
4%
insensitivity to pain
3%
—
vulvovaginitis
4%
4%
emotional
3%
—
vulva infections
4%
4%
immunodeficiency
3%
—
refuses treatment
4%
4%
changes in the blood
3%
—
hyperplasia of endometrium of uterus
10%
10%
there are no complaints
6%
1%
paranoia
2%
2%
scarring
3%
—
consequences of childbirth
2%
2%
endometrial hyperplasia
15%
10%
suspicion
2%
2%
high temperature
8%
3%
time of year
2%
2%
infertility female
10%
5%
intra-phase infections
4%
4%
appendages of the uterus
10%
5%
intoxication
3%
—
female pelvic organs
11%
7%
atypical endometrial hyperplasia
11%
7%
benign neoplasms
14%
10%